Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 4, Pages 791-801
Publisher
Informa UK Limited
Online
2016-12-25
DOI
10.1080/21645515.2016.1248326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections
- (2016) William E. Sause et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Status of vaccine research and development of vaccines for Staphylococcus aureus
- (2016) Birgitte K. Giersing et al. VACCINE
- Differential Interaction of the Staphylococcal Toxins Panton–Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors
- (2015) András N. Spaan et al. JOURNAL OF IMMUNOLOGY
- A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults
- (2015) Michael Nissen et al. VACCINE
- Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial
- (2015) Jack Levy et al. Human Vaccines & Immunotherapeutics
- Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins ofStaphylococcus aureuswith a single human monoclonal antibody
- (2014) Harald Rouha et al. mAbs
- A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus aureus Infection
- (2013) Stephanie A. Fritz et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage
- (2013) Elisabeth Botelho-Nevers et al. Expert Review of Vaccines
- Prevalence of Methicillin-ResistantStaphylococcus aureusin a Combat Support Hospital in Iraq
- (2013) Edgie-Mark Co et al. MILITARY MEDICINE
- Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model
- (2013) Hatice Karauzum et al. PLoS One
- Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
- (2013) Bryan Berube et al. Toxins
- Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010
- (2012) Michael L. Landrum et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections
- (2012) R. P. Adhikari et al. JOURNAL OF INFECTIOUS DISEASES
- Staphylococcal α-Toxin Induces a Higher T Cell Proliferation and Interleukin-31 in Atopic Dermatitis
- (2011) Margarete Niebuhr et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq
- (2010) X.-Z. HUANG et al. EPIDEMIOLOGY AND INFECTION
- Chlorhexidine-Impregnated Cloths to Prevent Skin and Soft-Tissue Infection in Marine Recruits: A Cluster-Randomized, Double-Blind, Controlled Effectiveness Trial
- (2010) Timothy J. Whitman et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
- (2010) John S. Cho et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR 2 and CD14 Mediate Innate Immunity and Lung Inflammation to Staphylococcal Panton-Valentine Leukocidin In Vivo
- (2010) A. Zivkovic et al. JOURNAL OF IMMUNOLOGY
- Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
- (2010) Adam D. Kennedy et al. JOURNAL OF INFECTIOUS DISEASES
- Enhancement of bacterial virulence by antibody neutralization of immune-activating toxins
- (2010) Pauline Yoong Virulence
- Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- (2010) Bettina Löffler et al. PLoS Pathogens
- Targeted Immunotherapy for Staphylococcal Infections
- (2009) Michael Otto BIODRUGS
- Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection
- (2009) M. Croze et al. CLINICAL MICROBIOLOGY AND INFECTION
- Towards the immune proteome of Staphylococcus aureus – The anti-S. aureus antibody response
- (2009) Silva Holtfreter et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Presence and Molecular Epidemiology of Virulence Factors in Methicillin-Resistant Staphylococcus aureus Strains Colonizing and Infecting Soldiers
- (2009) M. W. Ellis et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
- (2008) E.L. Brown et al. CLINICAL MICROBIOLOGY AND INFECTION
- Vaccination and passive immunisation against Staphylococcus aureus
- (2008) Adam C. Schaffer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Panton‐Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community‐Associated Methicillin‐ResistantStaphylococcus aureusDisease
- (2008) Juliane Bubeck Wardenburg et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started